source
- Telix to acquire ITM Isotope for $1.65 billion, targeting radioligand therapy marketTelix Pharmaceuticals announced it will acquire ITM Isotope Technologies Munich for $1.65 billion upfront, securing a radiopharmaceutical supply network. The acquisition brings an R&D pipeline cen…
- Novo Nordisk vows to launch five multi-blockbuster drugs by 2030 as it shifts toward consumer-style productsNovo Nordisk used its London capital markets day to reassure investors that the company will broaden its pipeline and market new medicines more like consumer products than traditional drugs. The C…